Delivery Order SPE2DB20D1047-SPE2DB24FF82P

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,239.63 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of BUTALBITAL-ASPIRIN-CAFFEINE CP 100S, a pharmaceutical product, to DLA facilities supporting the Department of Defense worldwide. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.87 Firm Fixed Price Delivery Order contract is for the supply of BUTALBITAL-ASPIRIN-CAFFEINE CP 100S, a pharmaceutical product. The contract has a period of performance through February 12, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,797.80 firm fixed-price contract is for the delivery of butalbital-aspirin-caffeine medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order, valued at $1,240.93, is for the procurement of 4566133505...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Butalbital-Aspirin-Caffeine prescription medication, with a ceiling value of $1,114.98. The order has a firm fixed price and a completion date of September 24, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award, valued at $1,017.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 28, 2025. The contract covers the procurement of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a major Defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $1,347.36 Firm Fixed Price delivery order contract is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S pharmaceutical products. The award date is September 9, 2024, with an ultimate completion date of September 10, 2024. This is a child contract under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.96 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,724.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.65, covers the delivery of 4567009809 ! BUTALB-ACETAMIN-CAFF 50-325-40 100S medication. The award has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB24FF82P
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,342.71, is for the delivery of 4,565,468,599 units of the pharmaceutical product BUTALBITAL-ASPIRIN-CAFFEINE CP 90S. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. The contract has a completion date of August 16, 2024 and utilizes a Firm Fixed Price pricing type. There is no set-aside designation for this award.

Generated 11/14/24, 9:08 AM